Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis

European Psychiatry

Volumn 18, Issue 6, 2003, Pages 318-319

  Himmerich, Hubertus ^a   Szegedi, Armin ^b   Klawe, Christoph ^b   Anghelescu, Ion ^c   Müller, Matthias J ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood brain barrier; Distigmine bromide; Multiple sclerosis

Indexed keywords

DISTIGMINE BROMIDE; METHYLPREDNISOLONE;

ACUTE PSYCHOSIS; ADULT; ANAMNESIS; ARTICLE; BLADDER DYSFUNCTION; BLOOD BRAIN BARRIER; CASE REPORT; CLINICAL FEATURE; DETRUSOR MUSCLE; DISEASE ACTIVITY; DISEASE COURSE; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MEDICAL EXAMINATION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOM; URINE RETENTION;

EID: 0344464923     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2002.11.001     Document Type: Article

References (9)

1. Claudio L, Brosnan CF. Effects of prazosin on the blood-brain barrier during experimental autoimmune encephalomyelitis. Brain Res 1992; 594(2):233-43.
2. Chaudhuri JD. Blood-brain barrier and infection. Med Sci Monit 2000;6(6):1213-22.
3. Kusuhara H, Sugiyama Y. Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2). Drug Discov Today 2001;6(4):206-12.
4. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats. Eur J Pharmacol 2001;415(2-3):157-64.
5. Melchior H. Drug therapy of detrusor dysfunction. Urologe 1983; 22(3):167-75.
6. Hertrich O. Psychopharmacologically qualified side effects with distigmine bromide therapy (UBRETID, BC 51). Nervenarzt 1976;46: 264-7.
7. Handler CE. Convulsions after distigmine bromide. Anaesth Intensive Care 1982;10(2):168-9.
8. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
9. Karch FE, Lasagna L. Adverse drug reactions. A critical review. J Am Med Assoc 1975;234(12):1236-41.